Rigel Pharma (RIGL) Announces Common Offering

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the offering are to be sold by Rigel, with the proceeds to be used to fund research and development activities and for general corporate purposes.

Jefferies& Company, Inc. and J.P. Morgan Securities LLC are acting as joint book-running managers for the proposed offering, with Citigroup acting as lead manager, and BMO Capital Markets, Piper Jaffray & Co. and Wells Fargo Securities, LLC acting as co-managers.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lycia Therapeutics raises $365M in upsized Nasdaq IPO
• Deep Sea Minerals files for U.S. public offering of ADS shares
• Independence Gold closes $6.25M private placement to fund drill program